Mechanisms in anti-inflammation and resolution: the role of lipoxins and aspirin-triggered lipoxins
Autor(a) principal: | |
---|---|
Data de Publicação: | 2001 |
Outros Autores: | |
Tipo de documento: | Artigo |
Idioma: | eng |
Título da fonte: | Brazilian Journal of Medical and Biological Research |
Texto Completo: | http://old.scielo.br/scielo.php?script=sci_arttext&pid=S0100-879X2001000500002 |
Resumo: | Multicellular host responses to infection, injury or inflammatory stimuli lead to the formation of a broad range of chemical mediators by the host. The integrated response of the host is essential to health and disease; thus it is important to achieve a more complete understanding of the molecular and cellular events governing the formation and actions of endogenous mediators of resolution that appear to control the duration of inflammation. Lipoxins are trihydroxytetraene-containing lipid mediators that can be formed during cell-cell interactions and are predominantly counterregulators of some well-known mediators of inflammation. Since this circuit of lipoxin formation and action appears to be of physiological relevance for the resolution of inflammation, therapeutic modalities targeted at this system are likely to have fewer unwanted side effects than other candidates and current anti-inflammatory therapies. Here, we present an overview of the recent knowledge about the biosynthesis and bioactions of these anti-inflammatory lipid mediators. |
id |
ABDC-1_eac623dcfdd9d571bc4393537d5e841f |
---|---|
oai_identifier_str |
oai:scielo:S0100-879X2001000500002 |
network_acronym_str |
ABDC-1 |
network_name_str |
Brazilian Journal of Medical and Biological Research |
repository_id_str |
|
spelling |
Mechanisms in anti-inflammation and resolution: the role of lipoxins and aspirin-triggered lipoxinsinflammationlipoxinsresolutionMulticellular host responses to infection, injury or inflammatory stimuli lead to the formation of a broad range of chemical mediators by the host. The integrated response of the host is essential to health and disease; thus it is important to achieve a more complete understanding of the molecular and cellular events governing the formation and actions of endogenous mediators of resolution that appear to control the duration of inflammation. Lipoxins are trihydroxytetraene-containing lipid mediators that can be formed during cell-cell interactions and are predominantly counterregulators of some well-known mediators of inflammation. Since this circuit of lipoxin formation and action appears to be of physiological relevance for the resolution of inflammation, therapeutic modalities targeted at this system are likely to have fewer unwanted side effects than other candidates and current anti-inflammatory therapies. Here, we present an overview of the recent knowledge about the biosynthesis and bioactions of these anti-inflammatory lipid mediators.Associação Brasileira de Divulgação Científica2001-05-01info:eu-repo/semantics/articleinfo:eu-repo/semantics/publishedVersiontext/htmlhttp://old.scielo.br/scielo.php?script=sci_arttext&pid=S0100-879X2001000500002Brazilian Journal of Medical and Biological Research v.34 n.5 2001reponame:Brazilian Journal of Medical and Biological Researchinstname:Associação Brasileira de Divulgação Científica (ABDC)instacron:ABDC10.1590/S0100-879X2001000500002info:eu-repo/semantics/openAccessFierro,I.M.Serhan,C.N.eng2001-04-27T00:00:00Zoai:scielo:S0100-879X2001000500002Revistahttps://www.bjournal.org/https://old.scielo.br/oai/scielo-oai.phpbjournal@terra.com.br||bjournal@terra.com.br1414-431X0100-879Xopendoar:2001-04-27T00:00Brazilian Journal of Medical and Biological Research - Associação Brasileira de Divulgação Científica (ABDC)false |
dc.title.none.fl_str_mv |
Mechanisms in anti-inflammation and resolution: the role of lipoxins and aspirin-triggered lipoxins |
title |
Mechanisms in anti-inflammation and resolution: the role of lipoxins and aspirin-triggered lipoxins |
spellingShingle |
Mechanisms in anti-inflammation and resolution: the role of lipoxins and aspirin-triggered lipoxins Fierro,I.M. inflammation lipoxins resolution |
title_short |
Mechanisms in anti-inflammation and resolution: the role of lipoxins and aspirin-triggered lipoxins |
title_full |
Mechanisms in anti-inflammation and resolution: the role of lipoxins and aspirin-triggered lipoxins |
title_fullStr |
Mechanisms in anti-inflammation and resolution: the role of lipoxins and aspirin-triggered lipoxins |
title_full_unstemmed |
Mechanisms in anti-inflammation and resolution: the role of lipoxins and aspirin-triggered lipoxins |
title_sort |
Mechanisms in anti-inflammation and resolution: the role of lipoxins and aspirin-triggered lipoxins |
author |
Fierro,I.M. |
author_facet |
Fierro,I.M. Serhan,C.N. |
author_role |
author |
author2 |
Serhan,C.N. |
author2_role |
author |
dc.contributor.author.fl_str_mv |
Fierro,I.M. Serhan,C.N. |
dc.subject.por.fl_str_mv |
inflammation lipoxins resolution |
topic |
inflammation lipoxins resolution |
description |
Multicellular host responses to infection, injury or inflammatory stimuli lead to the formation of a broad range of chemical mediators by the host. The integrated response of the host is essential to health and disease; thus it is important to achieve a more complete understanding of the molecular and cellular events governing the formation and actions of endogenous mediators of resolution that appear to control the duration of inflammation. Lipoxins are trihydroxytetraene-containing lipid mediators that can be formed during cell-cell interactions and are predominantly counterregulators of some well-known mediators of inflammation. Since this circuit of lipoxin formation and action appears to be of physiological relevance for the resolution of inflammation, therapeutic modalities targeted at this system are likely to have fewer unwanted side effects than other candidates and current anti-inflammatory therapies. Here, we present an overview of the recent knowledge about the biosynthesis and bioactions of these anti-inflammatory lipid mediators. |
publishDate |
2001 |
dc.date.none.fl_str_mv |
2001-05-01 |
dc.type.driver.fl_str_mv |
info:eu-repo/semantics/article |
dc.type.status.fl_str_mv |
info:eu-repo/semantics/publishedVersion |
format |
article |
status_str |
publishedVersion |
dc.identifier.uri.fl_str_mv |
http://old.scielo.br/scielo.php?script=sci_arttext&pid=S0100-879X2001000500002 |
url |
http://old.scielo.br/scielo.php?script=sci_arttext&pid=S0100-879X2001000500002 |
dc.language.iso.fl_str_mv |
eng |
language |
eng |
dc.relation.none.fl_str_mv |
10.1590/S0100-879X2001000500002 |
dc.rights.driver.fl_str_mv |
info:eu-repo/semantics/openAccess |
eu_rights_str_mv |
openAccess |
dc.format.none.fl_str_mv |
text/html |
dc.publisher.none.fl_str_mv |
Associação Brasileira de Divulgação Científica |
publisher.none.fl_str_mv |
Associação Brasileira de Divulgação Científica |
dc.source.none.fl_str_mv |
Brazilian Journal of Medical and Biological Research v.34 n.5 2001 reponame:Brazilian Journal of Medical and Biological Research instname:Associação Brasileira de Divulgação Científica (ABDC) instacron:ABDC |
instname_str |
Associação Brasileira de Divulgação Científica (ABDC) |
instacron_str |
ABDC |
institution |
ABDC |
reponame_str |
Brazilian Journal of Medical and Biological Research |
collection |
Brazilian Journal of Medical and Biological Research |
repository.name.fl_str_mv |
Brazilian Journal of Medical and Biological Research - Associação Brasileira de Divulgação Científica (ABDC) |
repository.mail.fl_str_mv |
bjournal@terra.com.br||bjournal@terra.com.br |
_version_ |
1754302930962350080 |